Research networks

Neumoexpertos in Prevention is a multidisciplinary group of doctors who work mainly in the field of Primary Health Care but also in other fields of medicine, such as Preventive Medicine and Public Health, Pediatrics, vaccine research... and whose fundamental objective is the promotion and leadership, of the prevention of pneumococcal infection, collaborating in the improvement of the assistance to the population, improving the professional competence of researchers and HCP (Health Care Professionals) dedicated to it, providing them with training tools as well as promoting research in the prevention of pneumococcal infection, in accordance with current legislation.

ReSViNET is the network for the study of the Respiratory Syncytial Virus (Respiratory Syncytial Virus Net) that aims to decrease the global burden of RSV infection through the advancement of research, providing scientific information and through participation in clinical trials. As part of its activities, ReSVINET organizes conferences and offers platforms in order to share the latest developments and reports on innovative studies in the field of this disease.

The mission of CIBERES is to fight respiratory diseases by promoting excellent research and its rapid and safe translation into clinical practice. Main objectives: Promote excellent research in respiratory diseases and contribute to the resolution of care problems in the field of respiratory diseases. Encourage the participation of its research groups in international research activities, especially those included in the European R+D+i Framework Programs. Promote the transfer of research results to society and, especially, to the productive sector. Train innovative and competitive researchers in respiratory diseases as well as disclose to society the main advances produced in respiratory research.

ESIGEM is a project on the Study on the Genetic Influence in Meningococcal Disease whose main objective is to evaluate the genetic influence in Meningococcal Disease and to correlate genetic and prognostic profiles

Meningococcal disease continues to be one of the main public health problems worldwide, with high mortality but also significant morbidity. The availability of vaccines against most of the most prevalent serogroups has allowed better control of the disease and a significant reduction in the number of cases. However, there is no universal vaccine against serogroup B, which explains most of the cases in settings such as Europe. The actual course of the meningococcal disease and the characterization of the sequelae in Spain are not well documented, and therefore, the main objectives of the MENDICOS project are to analyze the course of meningococcal disease and the characterization of the sequelae in children in Spain.

Evaluation of the influence of the genetic component and vitamin D levels on individual susceptibility and prognosis of infection by influenza virus, respiratory syncytial virus, and other respiratory agents.

GENDRES main objectives: Determine the genetic basis of individual susceptibility to respiratory infections, paying particular attention to those caused by respiratory syncytial virus (RSV) due to their prevalence and importance in children and their possible differential role with respect to other etiological agents, to examine the rate and pattern of viral infection/co-infection in children with infections respiratory using molecular diagnostic techniques and to study the pattern of cytokines secreted by the respiratory epithelium in the pathogenesis of ARIs and its correlation with the pattern of infection and clinical markers.

The Galician Pediatric Research Network was formally established on April 9, 2008 and its mission is to facilitate and promote pediatric research within the framework of the Galician Pediatric Society. Its objective, therefore, is to disseminate, implement and channel any research project in pediatrics, and facilitate its dissemination from and within society and from and in other national and international scientific societies.

The Translational Research Network in Pediatric Infectious Diseases is a network of clinical research networks, currently in the process of being endorsed by the Carlos III Health Institute, and coordinated by Dr. Federico Martinón-Torres (Santiago University Clinical Hospital) and Dr. Cristina Calvo (La Paz Hospital,Madrid). GENVIP greatly contributes to RITIP through the establishment of a number of national and international clinical networks of pediatric patients with infectious pathologies. This work is allowing the collection of numerous clinical data, as well as the creation of an important biobank, both key to the development of future scientific research.

Our research group participates as a National Node (Spanish National Hub - RECLIP) in the IHI (Innovative Health Initiatives) project of the European network of pediatric clinical trials conect4children (IMI2 JU GA 777389 with the collaboration of H2020 and EFPIA). RECLIP's main objective is to serve as an organization capable of providing a fully developed and professionalized network of the best national units for clinical trials in the pediatric population. RECLIP's mission is to provide sponsors of clinical trials with the appropriate environment and infrastructure, through the excellence of our clinical research network sites, in order to carry out pediatric clinical trials in pre-qualified sites that belong to network.